Table of Contents Table of Contents
Previous Page  368 / 1851 Next Page
Information
Show Menu
Previous Page 368 / 1851 Next Page
Page Background

Preclinical data

Relative EGFr niveau

40 50 60 70 80 Gy

TCD

50

Akimoto T 1999;Schmidt-Ullrich 1997

Milas L 2000;

RT+cetuximab

RT

Krause M 2005